The Latest in Immunotherapy

The Journal of Community and Supportive Oncology

Immunotherapies shape the treatment landscape for hematologic malignancies

August 15, 2018

Hematology News

Groups release guidelines for CAR T treatment in children

August 10, 2018

Oncology Practice

Melanoma survival shorter in those given high dose glucocorticoids for ipilimumab-induced hypophysitis

July 18, 2018

Oncology Practice

Checkpoint inhibitors in autoimmune disease: More flares, better cancer outcomes

June 25, 2018

The Journal of Community and Supportive Oncology

Tumor heterogeneity: a central foe in the war on cancer

June 21, 2018

Oncology Practice

FDA database reveals many rheumatic and musculoskeletal adverse events on immunotherapies

June 15, 2018

Oncology Practice

MRD-negative status signals better outcomes in CAR T–treated ALL

June 5, 2018

Oncology Practice

New ‘immune checkpoint’ vaccine shows promise in treating colorectal cancer

May 25, 2018

Oncology Practice

Is cancer immunotherapy more effective in men than women?

May 16, 2018

Hematology News

Low microbiota diversity linked to poor survival after transplant

March 22, 2018

Hematology News

Outpatient CAR T infusions feasible using liso-cel

March 12, 2018

Oncology Practice

Cancer groups offer guidance on immune-related adverse events

March 9, 2018

Oncology Practice

ERV expression may predict response to immune checkpoint blockade in ccRCC, other solid tumors

February 9, 2018

Oncology Practice

Two biomarkers predict immunotherapy response for NSCLC

February 6, 2018

Hematology News

AML immune profiles correlate with relapse-free survival

February 4, 2018